Clemens Grabher
Papers
2
Total Citations
57
H-Index
2
About
Clemens Grabher is a pioneering researcher in the fields of drug discovery and inflammation biology, with a particular focus on leveraging zebrafish as a model organism. His major contributions center on developing automated, high-content assays that transform how researchers screen for anti-inflammatory compounds. In his most-cited work, "Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish" (2012), Grabher demonstrated that zebrafish larvae are uniquely suited for whole-animal small molecule screens due to their small size, ease of manipulation, and ability to absorb compounds directly from bathing water. This breakthrough allows for rapid, cost-effective testing of thousands of compounds in a living system, bridging the gap between in vitro assays and mammalian models. With over 57 combined citations across two versions of this seminal paper, his work has significantly impacted preclinical drug development. Grabher’s innovative approach has accelerated the identification of novel therapeutics for inflammatory diseases, making him a key figure in translational pharmacology and a valuable resource for students and researchers exploring high-throughput in vivo screening techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2